SPECIALTY / DIRECT CATALOG PRICING
Kisspeptin-10
Kisspeptin-10 is the C-terminal 10-amino-acid fragment of kisspeptin and the minimal sequence with full intrinsic kisspeptin-receptor activity in experimental systems.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Specialty
- 10 mgPricing by inquiry · AvailableSelect
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Kisspeptin-10 is the C-terminal 10-amino-acid fragment of kisspeptin and the minimal sequence with full intrinsic kisspeptin-receptor activity in experimental systems.
The specialty classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Specialty
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Kisspeptin-10 is the C-terminal 10-amino-acid fragment of kisspeptin and the minimal sequence with full intrinsic kisspeptin-receptor activity in experimental systems.
- Research covered
- A small controlled physiology study administered bolus and continuous intravenous kisspeptin-10 to healthy men and measured luteinizing-hormone pulse characteristics and reproductive hormones. A proof-of-concept study also examined men with type 2 diabetes and mild biochemical hypogonadism.
- Important limit
- These were small, controlled endocrine-physiology studies, not evidence for unsupervised use or for the catalog's 10 mg vial. Results are limited to the studied participants, routes, sampling periods, and verified research preparations.
FACTUAL FAQ
Kisspeptin-10 catalog questions
What formats are currently listed?
10 mg. Current price and stock state appear above.
What did researchers study?
A small controlled physiology study administered bolus and continuous intravenous kisspeptin-10 to healthy men and measured luteinizing-hormone pulse characteristics and reproductive hormones. A proof-of-concept study also examined men with type 2 diabetes and mild biochemical hypogonadism.
What is the most important evidence limit?
These were small, controlled endocrine-physiology studies, not evidence for unsupervised use or for the catalog's 10 mg vial. Results are limited to the studied participants, routes, sampling periods, and verified research preparations.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
